NeuBase Therapeutics, Inc. Retained Earnings
NeuBase Therapeutics, Inc. had Retained Earnings of -$116.47 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-09
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$116.47M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$114.65M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$111.21M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$107.11M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2023-09-30 | -$116.47M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$114.65M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$111.21M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$107.11M 10-Q · filed 2023-11-09 | |
| 2022-09-30 | -$102.74M 10-QT · filed 2023-06-05 | |
| 2022-06-30 | -$95.11M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$86.62M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$76.70M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | -$68.97M 10-K · filed 2022-12-21 | |
| 2021-06-30 | -$61.81M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$53.15M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$47.63M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | -$43.56M 10-K · filed 2021-12-23 | |
| 2020-06-30 | -$39.68M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | -$35.88M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$31.51M 10-Q · filed 2020-03-26 | |
| 2019-09-30 | -$26.17M 10-K · filed 2020-12-23 | -$27.00M 10-K · filed 2020-01-10 |
| 2019-06-30 | -$124.50M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$3.56M 10-Q · filed 2020-05-14 | -$123.37M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$1.53M 10-Q · filed 2020-03-26 | -$122.22M 10-Q · filed 2019-02-14 |
| 2018-09-30 | -$41.95K 10-K · filed 2020-01-10 | -$121.33M 10-K · filed 2019-01-03 |
| 2018-06-30 | -$114.97M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$114.42M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$112.24M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | -$108.09M 10-K · filed 2019-01-03 | |
| 2017-06-30 | -$102.84M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$98.94M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$91.25M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$84.28M 10-K · filed 2017-12-15 | |
| 2016-06-30 | -$77.64M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$69.94M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$64.66M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | -$58.51M 10-K · filed 2016-12-22 | |
| 2015-06-30 | -$54.60M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$51.26M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$47.91M 10-Q · filed 2015-02-10 | |
| 2014-09-30 | -$43.31M 10-K · filed 2015-12-14 | |
| 2014-06-30 | -$40.23M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | -$21.63M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | -$21.63M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$34.18M 10-K · filed 2014-12-22 | -$21.63M 10-K · filed 2013-12-27 |
| 2013-06-30 | -$21.63M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | -$21.63M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | -$21.63M 10-Q · filed 2013-02-19 | |
| 2012-09-30 | -$21.63M 10-K · filed 2013-12-27 | |
| 2012-06-30 | -$21.63M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | -$21.63M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$21.63M 10-Q/A · filed 2012-02-14 | |
| 2011-09-30 | -$21.63M 10-K · filed 2013-01-09 | |
| 2011-06-30 | -$21.63M 10-Q · filed 2011-08-15 | |
| 2010-09-30 | -$21.63M 10-K/A · filed 2012-01-18 |